# Development of a Live Attenuated Rotavirus Vaccine as a Human Infection Challenge Model

> **NCT04123119** · NA · COMPLETED · sponsor: **Centre for Infectious Disease Research in Zambia** · enrollment: 22 (actual)

## Conditions studied

- Diarrhoeal Disease

## Interventions

- **BIOLOGICAL:** Rotavirus vaccine

## Key facts

- **NCT ID:** NCT04123119
- **Lead sponsor:** Centre for Infectious Disease Research in Zambia
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-22
- **Primary completion:** 2019-05-10
- **Final completion:** 2019-05-10
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2019-10-14

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04123119

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04123119, "Development of a Live Attenuated Rotavirus Vaccine as a Human Infection Challenge Model". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04123119. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*